Epilepsy burden shifts as aging and health inequalities persist
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-Oct-2026 14:15 ET (31-Oct-2026 18:15 GMT/UTC)
Epilepsy remains a major global health challenge, with its burden increasingly shaped by population aging and unequal access to care. Now, researchers show that although epilepsy mortality has declined substantially, 87.9% of associated disability-adjusted life years are concentrated in low- and lower-middle-income countries. In China, regional, urban-rural, and healthcare-tier disparities persist, while stroke-related epilepsy and aging populations are reshaping disease patterns and creating new demands for prevention, diagnosis, and long-term care globally.
AI-based “tissue clocks” can estimate the biological age of human organs from histological images, researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Ludwig Boltzmann Institute for Network Medicine (LBI-NetMed) at the University of Vienna showed. By analyzing more than 25,000 tissue samples across 40 tissue types, their study reveals that organs age at different rates throughout life and that these changes can even be detected from blood samples. The findings, published in Nature Medicine (DOI: 10.1038/s41591-026-04566-5), provide a new framework for understanding aging and may open new avenues for disease monitoring and early diagnosis.
Blood tests measuring plasma p-tau217 offer a promising, non-invasive alternative for Alzheimer's disease diagnosis. In a multicenter head-to-head evaluation, researchers compared nine commercial p-tau217 assays. While seven assays demonstrated high diagnostic accuracy for detecting amyloid pathology, two showed substantially lower performance. The findings emphasize that these tests are not interchangeable and require tailored calibration for clinical use.